Asalyxa Bio

Asalyxa Bio is an immunocyte-targeting therapy developer dedicated to creating novel treatments for significant unmet medical needs caused by abnormal immune signaling. The company's platform technology has broad applications across a wide range of disease areas and conditions, enabling the direct delivery of both existing and innovative drugs to overactive immune cells.